Congratulations to the team at Halo Therapeutics, who have won the ‘BioSeed ‘One to Watch’ Award for Therapeutics’ at the OBN Awards. Halo is developing pan coronavirus antivirals for home use by COVID-19 patients, based on groundbreaking discoveries made during the lockdowns. The award was collected by Prof Imre Berger, who is co-founder and CSO of Halo, and a Co-Director of the Bristol BioDesign Institute. Halo was founded on IP generated through BrisSynBio.
